Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?

Biliary tract cancer (BTC) includes a heterogeneous group of aggressive and rare hepatobiliary malignancies, including gallbladder cancer, ampullary carcinomas, intrahepatic cholangiocarcinoma (iCCA), and extrahepatic cholangiocarcinoma, further subclassified into distal (dCCA) and perihilar cholang...

Full description

Bibliographic Details
Main Authors: Angela Dalia Ricci, Alessandro Rizzo
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Medicina
Subjects:
n/a
Online Access:https://www.mdpi.com/1648-9144/57/12/1301
Description
Summary:Biliary tract cancer (BTC) includes a heterogeneous group of aggressive and rare hepatobiliary malignancies, including gallbladder cancer, ampullary carcinomas, intrahepatic cholangiocarcinoma (iCCA), and extrahepatic cholangiocarcinoma, further subclassified into distal (dCCA) and perihilar cholangiocarcinoma (pCCA) [...]
ISSN:1010-660X
1648-9144